Overview

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study allows patients who need a new anti-HIV treatment to take tenofovir disoproxil fumarate (tenofovir DF), an experimental drug. This study also looks at any side effects the drug causes.
Phase:
N/A
Details
Lead Sponsor:
Gilead Sciences
Treatments:
Anti-Retroviral Agents
Tenofovir